JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics

Published online July 20, 2026

To the Editor, While biologic medications are frequently used to treat inflammatory skin diseases, patients have experienced paradoxical skin dis...

read more
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum

Published online July 28, 2026

Patients are increasingly turning to social media for disease/treatment advice and support. 1 This has varying benefits 2 but involve...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Improvement of Rosacea With Tirzepatide: A Case Report

Published online July 28, 2026

Tirzepatide is a dual glucagon-like pedtide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) agonist and is primarily used ...

read more
Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

Published online July 31, 2026

Psoriasis is a chronic immune‑mediated inflammatory skin disease that is strongly associated with metabolic dysregulation and excess ...

read more
Use of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals

Published online July 29, 2026

Eczema is a prevalent, chronic skin condition with the highest burden among skin disorders globally, affecting approximately 20% of chi...

read more
Clinical Characteristics and Time to Onset of JAK-Inhibitor–Associated Acne: A Retrospective Chart Review Study

Published online July 29, 2026

Janus kinase (JAK) inhibitors are increasingly prescribed for inflammatory and autoimmune diseases, including atopic dermatitis (AD), a...

read more
Improved Sleep Quality in Psoriasis Patients Under Biologicals: A Prospective Observational Study

Published online July 31, 2026

Psoriatic disease is a common chronic immune-mediated systemic inflammatory disease, most often presenting as chronic plaque psoriasis ...

read more
Molluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment

Published online July 31, 2026

Molluscum contagiosum (MC), caused by the molluscum contagiosum virus (MCV), is a cutaneous infection that commonly affects children. 1...

read more
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex

Published online July 31, 2026

With an estimated global prevalence of >9% across all ages, acne vulgaris is one of the most common skin disorders. 1 However, acne...

read more
Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial

Published online July 31, 2026

Rosacea is a chronic inflammatory facial skin condition characterized by episodic or persistent erythema, edema, telangiectasias, and/o...

read more
Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis

Published online July 31, 2026

Psoriasis is a chronic inflammatory condition affecting the skin. 1,2 Pathophysiology involves Th1- and Th17-driven inflammation with ...

read more
Atopic Dermatitis Flare Following Initiation of Nemolizumab

Published online July 27, 2026

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense pruritus and recurrent flares.1 Despite advanc...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Reining in Medicare Spending on Skin Substitutes: What the 2026 Reforms Mean for Dermatology

Published online July 27, 2026

Medicare Part B spending on skin substitute products rose from $256 million in 2019 to more than $10 billion in 2024. 1 A 2025 brief r...

read more
Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis

Published online July 20, 2026

Psoriasis is a chronic, immune-mediated inflammatory condition that affects approximately 3% of the adult population in the United Stat...

read more
Assessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis

Published online July 20, 2026

To the Editor, Eight percent (8%) of adults are affected by contact allergies. 1 Patch testing is the gold standard for diagnosis of allergic cont...

read more
Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort

Published online July 20, 2026

Dear Editor, Psoriasis is recognized as a systemic disease with various comorbidities that increase disease burden and complicate treatment. 1 R...

read more
Risankizumab Associated With Lower Incident Depression and Sleep Disorders in Psoriasis: A TriNetX Study

Published online July 17, 2026

To the Editor, Psoriasis (PsO) is a chronic inflammatory disease associated with significant psychiatric comorbidity. 1 Emerging evidence sugges...

read more
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape

Published online July 16, 2026

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, and sinus tracts th...

read more
Sun Protection: Beyond Sunscreen

Published online July 14, 2026

Ultraviolet (UV) radiation from sun exposure causes photosensitivity, photoaging, and photocarcinogenesis. 1 While dermatologists rout...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD featuring GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Hair Loss Awareness Month

| Featured Articles, Hair, Latest News | No Comments
Advancing Hair Loss Solutions As August marks Hair Loss Awareness Month, the Journal of Drugs in Dermatology (JDD) continues to champion evidence-based approaches for practicing dermatologists navigating this challenging field.…

“Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care

| Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…

Photoprotection 2026: Clinical Updates, Global Trends, and the US Regulatory Evolution

| JDD Highlights, JDD Webinars, The Latest | No Comments
The photoprotection landscape is currently defined by a widening gap between global innovation and US regulatory constraints. This webinar provides a clear roadmap through the complexity, resolving the ambiguity surrounding…
Journal of Drugs in Dermatology JDD featuring GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

| Featured Articles, GLP-1, Latest News | No Comments
GLP-1 Receptor Agonists and Psoriasis: The Next Frontier in Metabolic Dermatology? A groundbreaking study published in the Journal of Drugs in Dermatology  highlights a compelling link between metabolic therapy and…
Journal of Drugs in Dermatology JDD featuring our current Author Spotlight features Nada Elbuluk, MD, MSc, FAAD, one of the co-authors of Public Interest in Hyperpigmentation: Insights From a Google Trends Analysis

Author Spotlight: Nada Elbuluk, MD, MSc, FAAD

| Author Spotlight, Dyspigmentation, Featured Articles, Latest News | No Comments
Check Out JDD’s Latest Author Spotlight  Our current Author Spotlight features Nada Elbuluk, MD, MSc, FAAD, one of the co-authors of Public Interest in Hyperpigmentation: Insights From a Google Trends…

Explore the JDDOnline Hyperpigmentation Microsite

| Featured Articles, Latest News | No Comments
Your ultimate, comprehensive hub for everything related to pigmentary disorders. Whether you are looking to deepen your clinical knowledge, catch up on the latest dermatological breakthroughs, or optimize your patient…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Who Wore (or taught) It Better: An Critical Appraisal of AI Generated Answers to Patient Questions About Mohs Surgery

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Vishal Patel and Kennedy Sun "Come with me if you want to live." That iconic statement from Arnold Schwarzenegger in T2 couldn't be more true today; if you…
Tune In

Follow Us